Ovid therapeutics Inc

Abrir

SetorSaúde

2.68 -0.74

Visão Geral

Variação de preço das ações

24h

Atual

Mín

2.63

Máximo

2.79

Indicadores-chave

By Trading Economics

Rendimento

-27M

-17M

EPS

-0.125

Margem de lucro

-2,366.017

Funcionários

23

EBITDA

-4.7M

-17M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+108.96% upside

Dividendos

By Acuity

Próximos Ganhos

12 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-5M

478M

Abertura anterior

3.42

Fecho anterior

2.68

Sentimento de Notícias

By Acuity

50%

50%

140 / 342 Ranking em Healthcare

Ovid therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

1 de jul. de 2026, 23:52 UTC

News
Correlated Moves
Social Media

Meta Platforms Inc. shares fell in after-market trading amid a broader tech market downturn, despite earlier gains on plans for a cloud computing business.

1 de jul. de 2026, 23:51 UTC

Social Media
News
Correlated Moves
ETF Constituents

Invesco QQQ Trust trading lower after Nasdaq 100 decline, reflecting a market shift away from technology stocks. Notable trades occurred at $737.25.

1 de jul. de 2026, 23:36 UTC

Correlated Moves
News

Ethereum is trading higher, buoyed by Bitcoin's recent gains. Earlier in the session, Ethereum peaked before pulling back slightly but has since regained ground.

1 de jul. de 2026, 23:36 UTC

News
Social Media

AMD shares are higher in after-market hours following a $36 million equity award announcement for CEO Lisa T. Su and positive discussions at HPE Discover 2026.

1 de jul. de 2026, 23:36 UTC

News
Correlated Moves

Ethereum is trading higher, supported by Bitcoin's recent strong move. It pulled back slightly from earlier session highs but remains above Tuesday's close.

1 de jul. de 2026, 23:31 UTC

News

United States Oil Fund LP advances in after-market trading, despite lower oil prices and mixed global equity performance. No specific news identified for the move.

1 de jul. de 2026, 23:16 UTC

Correlated Moves
News

Qualcomm Inc. shares rose in after-market trading, reflecting a modest gain since Wednesday's close, amid KLA Corp's price increase and recent index removals.

1 de jul. de 2026, 23:06 UTC

News
ETF Constituents

Vanguard Growth ETF declines in after-market trading, reversing earlier gains. Broader market faces pressure from economic data and geopolitical tensions.

1 de jul. de 2026, 23:06 UTC

Social Media
News
ETF Constituents

The SPDR Dow Jones Industrial Average ETF Trust declined slightly in after-market hours, reflecting broader market trends and mixed investor sentiment.

1 de jul. de 2026, 23:06 UTC

News
Correlated Moves
ETF Constituents

The Nasdaq 100 Index shows slight gains in after-market hours, while the Vanguard Information Technology ETF remains roughly flat amid stable trading conditions.

1 de jul. de 2026, 22:51 UTC

News

Buy rating upgrade from Guggenheim boosts CHKP in after-market.

1 de jul. de 2026, 20:07 UTC

News
Social Media

American Airlines shares rise as Bernstein raises price target to $23. FAA's approval for supersonic flights may boost investor sentiment.

1 de jul. de 2026, 20:07 UTC

News

The Nikkei 225 Index is lower in after-market hours, reflecting significant volatility amid broader market sell-offs in technology stocks. No specific news was identified.

1 de jul. de 2026, 20:05 UTC

Correlated Moves
ETF Constituents
News

The iShares MSCI United Kingdom ETF is lower today amid reduced Bank of England rate hike expectations and a decline in the U.K. Manufacturing PMI.

1 de jul. de 2026, 20:04 UTC

Macro News
Macro Event
ETF Constituents
News

The Communication Services Select Sector SPDR Fund is rising amid a broader market rally, driven by strong gains in Meta Platforms and the overall sector.

1 de jul. de 2026, 20:04 UTC

Social Media
News
Macro Event
ETF Constituents

VanEck Gold Miners ETF declines as broader market dynamics weigh on investor sentiment, despite a rise in spot gold prices to $4,085 an ounce.

1 de jul. de 2026, 20:04 UTC

Social Media
News
ETF Constituents

iShares China Large-Cap ETF gains amid positive sentiment following the China foreign minister's remarks on U.S. relations and strong performance from constituent stocks.

1 de jul. de 2026, 20:04 UTC

Correlated Moves
News
Event
Macro Event
Social Media

iShares 20+ Year Treasury Bond ETF declines amid rising Treasury yields and comments from Federal Reserve Chair Kevin Warsh on high prices. The ETF went ex-dividend today at $0.31803.

1 de jul. de 2026, 20:03 UTC

News

Piper Sandler raised Illumina's price target to $200, contributing to shares trading higher today. The company also expanded its board with a new appointment.

1 de jul. de 2026, 20:03 UTC

Macro Event
News

Willis Towers Watson PLC launched its expanded CyMax Facility for cyber insurance aimed at SMEs in the EMEA region, boosting shares during Wednesday's session.

1 de jul. de 2026, 20:03 UTC

News
Correlated Moves

NXP Semiconductors NV's stock is lower amid negative assessment from StockStory, citing revenue concerns and lagging growth compared to industry averages.

1 de jul. de 2026, 20:03 UTC

Social Media
News

Adobe Inc. is trading higher during Wednesday's session, with analysts suggesting potential for recovery amid ongoing interest in the software sector despite recent challenges.

1 de jul. de 2026, 20:03 UTC

Social Media
News

Microsoft's stock rises on a five-year partnership with Haleon to enhance AI capabilities. A Jefferies survey shows Azure gaining traction over AWS.

1 de jul. de 2026, 20:02 UTC

News

Align Technology Inc. shares are higher as the company addresses an antitrust investigation and announces plans for its second-quarter 2026 financial results.

1 de jul. de 2026, 20:02 UTC

Macro Event
Social Media
News

Automatic Data Processing's stock rose following the ADP National Employment Report, which showed a 98,000 increase in private sector jobs for June.

1 de jul. de 2026, 20:02 UTC

Correlated Moves
News

Analog Devices Inc. shares are lower today, impacted by a significant decline in the semiconductor sub-sector and broader market volatility.

1 de jul. de 2026, 19:56 UTC

Correlated Moves
News

The U.S. dollar is near two-week lows, impacting the Invesco Currencyshares Japanese Yen Trust, which is trading roughly flat amid ongoing geopolitical tensions.

1 de jul. de 2026, 19:56 UTC

Macro Event
Correlated Moves
ETF Constituents
Macro News
News

Energy Select Sector SPDR Fund declines amid broader energy sector downturn and falling crude oil prices. ExxonMobil and Schlumberger contribute to negative performance.

1 de jul. de 2026, 19:51 UTC

Social Media
News
Macro Event

Cognizant Technology Solutions shares rise following the launch of Cognizant Neuro AI Trust, despite HSBC lowering its price target to $68 from $80.

1 de jul. de 2026, 19:47 UTC

Correlated Moves
Social Media
News

Alphabet Inc shares are higher as the company surpasses its $1 billion investment target in Africa, despite mixed social media sentiment regarding recent legal challenges.

Comparação entre Pares

Variação de preço

Ovid therapeutics Inc Previsão

Preço-alvo

By TipRanks

108.96% parte superior

Previsão para 12 meses

Média 5.6 USD  108.96%

Máximo 7 USD

Mínimo 4 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Ovid therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

7

Comprar

0

Manter

0

Vender

Sentimento

By Acuity

140 / 342 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Ovid therapeutics Inc

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing soticlestat, a novel cholesterol 24 hydroxylase inhibitor, which is in Phase 3 clinical trials for the potential treatment of patients with resistant epilepsies; OV329, a GABA aminotransferase inhibitor which is in Phase 1 clinical trials for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It also develops OV815, that focuses on the mutations associated with KIF1A-associated neurological disorder (KAND); OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial; OV825, has advanced to potential candidate lead identification for the rare neurodevelopmental condition HNRNPH2 (Bain Syndrome); and OV882, a short hairpin RNA gene therapy for the treatment of Angelman syndrome. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
help-icon Live chat